Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Receivables: 2017-2025

Historic Change in Receivables for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to $50.7 million.

  • Organogenesis Holdings' Change in Receivables rose 1799.80% to $50.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.1 million, marking a year-over-year increase of 365.91%. This contributed to the annual value of $31.8 million for FY2024, which is 674.11% up from last year.
  • Organogenesis Holdings' Change in Receivables amounted to $50.7 million in Q3 2025, which was up 162.56% from $19.3 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Change in Receivables registered a high of $50.7 million during Q3 2025, and its lowest value of -$7.3 million during Q4 2023.
  • Moreover, its 3-year median value for Change in Receivables was $3.4 million (2023), whereas its average is $8.2 million.
  • In the last 5 years, Organogenesis Holdings' Change in Receivables tumbled by 166.42% in 2023 and then skyrocketed by 1,799.80% in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Change in Receivables stood at $8.5 million in 2021, then slumped by 132.21% to -$2.7 million in 2022, then tumbled by 166.42% to -$7.3 million in 2023, then skyrocketed by 220.60% to $8.8 million in 2024, then skyrocketed by 1,799.80% to $50.7 million in 2025.
  • Its last three reported values are $50.7 million in Q3 2025, $19.3 million for Q2 2025, and -$5.7 million during Q1 2025.